Lilly: Andreessen Horowitz Partnering With Lilly On $500 Million Biotech Ecosystem Venture Fund

Andreessen Horowitz (a16z) Bio + Health announced a newly formed and first-of-its-kind venture capital fund to fuel broader innovation in human health in partnership with Eli Lilly and Company (Lilly). The Biotech Ecosystem Venture Fund aims to drive transformative progress in healthcare by investing in therapeutic platforms and technology companies that can bring new medicines and disease treatments to improve patients' lives. The post Andreessen Horowitz Partnering With Lilly On $500 Million Biotech Ecosystem Venture Fund appeared first on Pulse 2.0.